Laser postionization secondary neutral mass spectrometry in tissue: A powerful tool for elemental and molecular imaging in the development of targeted drugs

Molecular Cancer Therapeutics

Volumn 7, Issue 7, 2008, Pages 1763-1771

  Wittig, Andrea ^a   Arlinghaus, Heinrich F ^b   Kriegeskotte, Christian ^b   Moss, Raymond L ^c   Appelman, Klaas ^d   Schmid, Kurt W ^a   Sauerwein, Wolfgang A G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c JOINT RESEARCH CENTRE   (Italy)

^d NUCLEAR RESEARCH AND CONSULTANCY GROUP NRG   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

4 BORONOPHENYLALANINE; BOROCAPTATE; BORON 10; BORON DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; EXPERIMENTAL NEOPLASM; GAMMA RADIATION; LASER; LASER POSTIONIZATION SECONDARY NEUTRAL MASS SPECTROMETRY; MALE; MASS SPECTROMETRY; MOLECULAR IMAGING; MOUSE; NEUTRON CAPTURE THERAPY; NONHUMAN; PRIORITY JOURNAL; SARCOMA; ANIMAL; BLOOD; DIAGNOSTIC IMAGING; DRUG DESIGN; METHODOLOGY; NUDE MOUSE; PATHOLOGY;

ANIMALS; BORON COMPOUNDS; DIAGNOSTIC IMAGING; DRUG DESIGN; GAMMA RAYS; LASERS; MALE; MASS SPECTROMETRY; MICE; MICE, NUDE; SARCOMA;

EID: 51049093823     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-08-0191     Document Type: Article

References (40)

1. Arlinghaus HF, Kriegeskotte C, Fartmann M, Wittig A, Sauerwein W, Lipinsky D. Mass spectrometric characterization of elements and molecules in cell cultures and tissues. Appl Surf Sci 2006;252:6941-8.
2. 10B concentration for boron neutron capture therapy using prompt γ-ray analysis. Acta Oncol 1995;34:517-23.
3. Snyder HR, Reedy AJ, Lennarj WJ. Synthesis of aromatic boronic acids. Aldehyde boronic acids and a boronic acid analog of tyrosine. J Am Chem Soc 1958;80:835-8.
4. Soloway AH, Hatanaka H, Davis MA. Penetration of brain and brain tumor. VII. Tumor binding sulfhydryl boron compounds. J Med Chem 1967;10:714-7.
5. Nicklas W, Baneux P, Boot R, et al. Recommendations for the health monitoring of rodent and rabbit colonies in breeding and experimental units. Lab Animal 2002;36:20-42.
6. Kageji T, Nagahiro S, Mizobuchi Y, Toi H, Nakagawa Y, Kumada H. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma - correlation between radiation dose and radiation injury and clinical outcome. Int J Radiat Oncol Biol Phys 2006;65:1446-55.
7. Hatanaka H. A revised boron-neutron capture therapy for malignant brain tumors. II. Interim clinical result with the patients excluding previous treatments. J Neurol 1975;209:81-94.
8. Sauerwein W, Zurlo A. The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects. Eur J Cancer 2002;38:S31-4.
9. Wittig A, Moss RL, Stecher-Rasmussen F, et al. Neutron activation of patients following Boron Neutron Capture Therapy of brain tumors at the High Flux Reactor (HFR) Petten (EORTC Trials 11961 and 11011). Strahlenther Onkol 2005;181:774-82.
10. Busse PM, Harling OK, Palmer MR, et al. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol 2003;62:111-21.
11. 10B in blood after boronophenylalanine-fructose administration in humans. Radiat Res 2001;155:611-8.
12. Bergenheim AT, Capala J, Roslin M, Henriksson R. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol 2005;71:287-93.
13. Kato I, Ono K, Sakurai Y, et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 2004;61:1069-73.
14. 18F-BPA PET. Head Neck 2006;28:850-5.
15. 10B- compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001). Int J Cancer 2008;122:1164-71.
16. 10B-L-boronophenylalanine-fructose injection. Am J Health Syst Pharm 2005;62:2608-10.
17. Ono K, Masunaga S-I, Suzuki M, Kinashi Y, Takagaki M, Akaboshi M. The combined effect of boronophenylalanine and borocaptate in boron neutron capture therapy for SCCVII tumors in mice. Int J Radiat Oncol Biol Phys 1999;43:431-6.
18. Dagrosa MA, Viaggi M, Kreimann E, et al. Selective uptake of p-borophenylalanine by undifferentiated thyroid carcinoma for boron neutron capture therapy. Thyroid 2002;12:7-12.
19. 10B-carrier in boron neutron capture therapy. Anticancer Res 2004;24:2975-83.
20. Michel J, Saverwein W, Wittig A, Balossier G, Zierold K. Subcellular localization of boron in cultured melanoma cells by electron energy-loss spectroscopy of freeze-dried cryosections. J Microsc 2003;210:25-34.
21. Kriegeskotte C, Möller J, Lipinsky D, et al. Imaging of atomic and molecular species in tissue with laser-SNMS for pharmaceutical studies. Surf Interface Anal 2006;38:121-5.
22. Wittig A, Wiemann M, Fartmann M, et al. Preparation of cells cultured on silicon wafers for mass spectrometry analysis. Microsc Res Tech 2005;66:248-58.
23. Fartmann M, Kriegeskotte C, Dambach S, Wittig A, Sauerwein W, Arlinghaus HF. Quantitative imaging of atomic and molecular species in cancer cultures with TOF-SIMS and Laser-SNMS. Appl Surf Sci 2004;231-232:428-31.
24. Arlinghaus HF, Fartmann M, Kriegeskotte C, et al. Subcellular imaging of cell cultures and tissue for boron localization with laser-SNMS. Surf Interface Anal 2004;36:698-701.
25. Bourdos N, Kollmer F, Benninghoven A, Sieber M, Galla HJ. Imaging of domain structures in a one-component lipid monolayer by time-of-flight secondary ion mass spectrometry. Langmuir 2000;16:1481-4.
26. Malmberg P, Nygren HK, Richter K, et al. Imaging of lipids in human adipose tissue by cluster ion TOF-SIMS. Microsc Res Technique 2007;70:828-35.
27. Zamenhof RG, Clement S, Lin K, Lui C, Ziegelmiller D, Harling OK. Monte Carlo treatment planning and high-resolution α-track autoradiography for neutron capture therapy. Strahlenther Onkol 1989;165:188-92.
28. Kiger WS III, Micca PL, Morris GM, Coderre JA. Boron micro-quantification in oral mucosa and skin following administration of a neutron capture therapy agent. Radiat Prot Dosimetry 2002;99:409-12.
29. Echlin P. Low-temperature microscopy and analysis. New York: Plenum Press; 1992.
30. Signor L, Varesio E, Staack RF, Starke V, Richter WF, Hopfgartner G. Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometry. J Mass Spectrom 2007;42:900-9.
31. Bennett BD, Zha X, Gay I, Morrison GH. Intracellular boron localization and uptake in cell cultures using imaging secondary ion mass spectrometry (ion microscopy) for neutron capture therapy for cancer. Biol Cell 1992;74:105-8.
32. Chandra S, Lorey DRI, Smith DR. Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: in vitro studies on human glioblastoma T98G cells. Radiat Res 2002;157:700-10.
33. Chandra S, Smith DR, Morrison GH. Subcellular imaging by dynamic SIMS ion microscopy. Anal Chem 2000;72:104A-14.
34. Yokoyama K, Miyatake S-I, Kajimoto Y, et al. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry. Radiat Res 2007;167:102-9.
35. Kollmer F, Bourdos N, Kamischke R, Benninghoven A. Nonresonant Laser-SNMS and TOF-SIMS analysis of sub-Am structures. Appl Surf Sci 2003;203:238-43.
36. Yokoyama K, Miyatake SI, Kajimoto Y, et al. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT. J Neurooncol 2006;78:227-32.
37. Ono K, Masunaga SI, Kinashi Y, et al. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 1996;34:1081-86.
38. Wittig A, Sauerwein WA, Coderre JA. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro. Radiat Res 2000;153:173-80.
39. Coderre JA, Glass JD, Fairchild RG, Roy U, Cohen S, Fand I. Selective targeting of boronophenylalanine to melanoma in BALB/c mice for neutron capture therapy. Cancer Res 1987;47:6377-83.
40. Trivillin VA, Heber EM, Nigg DW, et al. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Radiat Res 2006;166:387-96.